Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

Johnson & Johnson clinical trials

Also known as J&J, JNJ.

The registry lists 3,718 studies whose lead sponsor is Johnson & Johnson or one of 114 companies grouped under it. 155 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the Johnson & Johnson studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 2,930
Terminated: 358
Active, not recruiting: 136
Recruiting: 135
Withdrawn: 88
No longer available: 18

Phase

Phase 1: 963
Phase 3: 864
Phase 2: 601
Phase 4: 319
Early Phase 1: 21

Where

United States: 1,587
Germany: 607
United Kingdom: 591
Belgium: 586
Spain: 508
France: 480

Focus areas

Conditions Johnson & Johnson leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 112 areas

Arthritis, Psoriatic38 Myopia37 Communicable Diseases36 Neoplasms36 Familial Primary Pulmonary Hypertension35 Attention Deficit Disorder with Hyperactivity34 Carcinoma, Non-Small-Cell Lung33 Lymphoma33 Dementia32 Osteoarthritis, Knee32 Influenza, Human31 Epilepsy30 Hypertension, Pulmonary30 Refractive Errors30 Necrosis29 Cataract27 Gastroesophageal Reflux27 Renal Insufficiency27 Ulcer27 Leukemia, Lymphocytic, Chronic, B-Cell26 Migraine Disorders26 Virus Diseases26 Depressive Disorder, Treatment-Resistant25 Leukemia25 Astigmatism24 Dermatitis, Atopic24 Chronic Pain23 Seizures23 Hepatitis B22 Colitis21 Mental Disorders21 Myelodysplastic Syndromes21 Tobacco Use Disorder21 Cancer Pain20 Low Back Pain20 Femoral Fractures19 Hepatitis B, Chronic19 Hip Dislocation, Congenital19 Intervertebral Disc Degeneration19 Lymphoma, Non-Hodgkin19 Asthma18 Coronary Artery Disease17 Hemorrhage17 Myocardial Infarction17 Liver Diseases16 Pain, Postoperative16 Peripheral Arterial Disease16 Respiratory Syncytial Virus Infections16 Eczema15 Fractures, Bone15 Inflammatory Bowel Diseases15 Rheumatic Diseases15 Spondylarthritis15 Spondylitis, Ankylosing15 Breast Neoplasms14 Kidney Diseases14 Leukemia, Myeloid, Acute14 Lymphoma, Mantle-Cell14 Heart Diseases13 Hematologic Neoplasms13 Lung Neoplasms13 Slipped Capital Femoral Epiphyses13 Headache12 Hypersensitivity12 Joint Diseases12 Osteoarthritis, Hip12 Pneumonia12 Sclerosis12 Urinary Bladder Neoplasms12 Epilepsies, Partial11 Kidney Failure, Chronic11 Presbyopia11 Carcinoma10 Colorectal Neoplasms10 Diabetic Neuropathies10 Esophagitis, Peptic10 Ischemic Stroke10 Lupus Erythematosus, Systemic10 Obesity10 Ovarian Neoplasms10 Pain10 Prostatic Neoplasms, Castration-Resistant10 Pulmonary Disease, Chronic Obstructive10 Rhinitis10 Scleroderma, Systemic10 Toothache10 Urinary Incontinence10 Urinary Tract Infections10

Studies

Recruiting first, then most recently updated. Showing 50 of 3,718. Browse all 3,718 →

A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker VolunteersRecruitingNCT07893158Phase 2
Sponsor listed in the registry: McNeil AB · First submitted after McNeil AB left Johnson & Johnson
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in KoreaNot yet recruitingNCT07890285
Sponsor listed in the registry: Janssen Korea, Ltd., Korea
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative ColitisRecruitingNCT04372108
Sponsor listed in the registry: Janssen Scientific Affairs, LLC
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)RecruitingNCT07062471Not applicable
Sponsor listed in the registry: Shockwave Medical, Inc. · First submitted after Shockwave Medical, Inc. became part of Johnson & Johnson
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07577843Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryRecruitingNCT06965504Not applicable
Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07577856Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedRecruitingNCT07665450Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA TherapeuticallyRecruitingNCT07654751Phase 4
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD TreatmentNot yet recruitingNCT07856420Phase 3
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted after Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
A Study to Assess Guselkumab in Participants With Moderate-to-Severe Inflammatory Bowel Disease in Real Life Italian SettingNot yet recruitingNCT07851207
Sponsor listed in the registry: Janssen-Cilag Ltd.
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple MyelomaRecruitingNCT07589634Phase 2
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderRecruitingNCT07573176Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter SystemRecruitingNCT07227532Not applicable
Sponsor listed in the registry: Biosense Webster, Inc. · Biosense Webster, Inc. — acquired company within the Johnson & Johnson group
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIRecruitingNCT05102019Not applicable
Sponsor listed in the registry: Shockwave Medical, Inc. · First submitted before Shockwave Medical, Inc. became part of Johnson & Johnson
A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative ColitisNot yet recruitingNCT07848737
Sponsor listed in the registry: Janssen-Cilag, S.A.
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)RecruitingNCT06635148Phase 2/3
Sponsor listed in the registry: Janssen Research & Development, LLC
Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® MultifocalRecruitingNCT07788521Not applicable
Sponsor listed in the registry: Johnson & Johnson Vision Care, Inc. · Johnson & Johnson Vision Care, Inc. — acquired company within the Johnson & Johnson group
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic StrokeNot yet recruitingNCT07760649
Sponsor listed in the registry: Neuravi Limited · First submitted after Neuravi Limited became part of Johnson & Johnson
A Study Comparing ETHICON™ 4000 Stapler System With Standard of Care Stapling Devices in Adults Undergoing Gastric and Thoracic ProceduresNot yet recruitingNCT07744568Not applicable
Sponsor listed in the registry: Ethicon Endo-Surgery
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaRecruitingNCT06651567Phase 2
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted before Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid TumorsRecruitingNCT07107230Phase 1
Sponsor listed in the registry: Janssen Research & Development, LLC
Evaluation of Approved Contact Lenses (CR-6657)RecruitingNCT07819305Not applicable
Sponsor listed in the registry: Johnson & Johnson Vision Care, Inc. · Johnson & Johnson Vision Care, Inc. — acquired company within the Johnson & Johnson group
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseRecruitingNCT06540833Phase 2
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted before Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial FibrillationNot yet recruitingNCT07845682Not applicable
Sponsor listed in the registry: Biosense Webster, Inc. · Biosense Webster, Inc. — acquired company within the Johnson & Johnson group
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating WomenRecruitingNCT07669077Phase 1
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)RecruitingNCT07807865Phase 3
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted after Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese PopulationRecruitingNCT06510205
Sponsor listed in the registry: Johnson & Johnson Medical (Shanghai) Ltd.
A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical PracticeRecruitingNCT07746583
Sponsor listed in the registry: Janssen-Cilag Kft.
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping CatheterRecruitingNCT07116525Not applicable
Sponsor listed in the registry: Biosense Webster, Inc. · Biosense Webster, Inc. — acquired company within the Johnson & Johnson group
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerRecruitingNCT06095089Phase 1
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisRecruitingNCT05652335Phase 1
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerRecruitingNCT06919965Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerRecruitingNCT05498428Phase 2
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With SchizophreniaRecruitingNCT07615426Phase 1
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of JNJ-89862175 for Treatment of Advanced Solid TumorsRecruitingNCT07223125Phase 1
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)RecruitingNCT07310095Phase 4
Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative ColitisRecruitingNCT07606339
Sponsor listed in the registry: Janssen-Cilag Pharma GmbH
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruitingNCT05179876Phase 3
Sponsor listed in the registry: Actelion · First submitted after Actelion became part of Johnson & Johnson
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT05923073Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative ColitisRecruitingNCT07302360
Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.
Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic LeukemiaRecruitingNCT06299540
Sponsor listed in the registry: Janssen Cilag S.A.S.
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsRecruitingNCT06706674Phase 3
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted before Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in FranceRecruitingNCT07451002
Sponsor listed in the registry: Janssen Cilag S.A.S.
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderRecruitingNCT05850689Phase 3
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted before Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerRecruitingNCT06319820Phase 3
Sponsor listed in the registry: Janssen Research & Development, LLC
A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in KoreaNot yet recruitingNCT07735793
Sponsor listed in the registry: Janssen Korea, Ltd., Korea
A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World SettingNot yet recruitingNCT07746765
Sponsor listed in the registry: Janssen Sciences Ireland UC
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderRecruitingNCT06229210Phase 3
Sponsor listed in the registry: Intra-Cellular Therapies, Inc. · First submitted before Intra-Cellular Therapies, Inc. became part of Johnson & Johnson
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerRecruitingNCT06385080Phase 1/2
Sponsor listed in the registry: Janssen Research & Development, LLC